Intracellular levels of p53 are tightly regulated through its ubiquitylation by MDM2 and subsequent degradation by the 26S proteasome [37], and p53 expression is frequently silenced in ER+ breast cancer [38]. Here, TP53 is linked to breast carcinoma.